Sign in
TVGNW Stock Price, Chart, Stats & News
Tevogen Bio Holdings Inc.
Save
9.38M
Market cap
–
Current P/E
–
Forward P/E
TVGNW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -686.47% |
ROE | 389.21% |
D/E | -0.96x |
Interest coverage ratio | -219.50x |
TVGNW valuation
P/E | – |
P/S | – |
P/B | -2.19x |
P/CF | -1.30x |
P/FCF | -1.34x |
P/OCF | -1.30x |
PEG | -0.21x |
EV multiple | -0.37x |
About
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company focused on developing ready-to-use, precision T cell therapies. Their research and development efforts span virology, oncology, and neurological conditions. The company's flagship experimental treatment, TVGN 489, is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID-19, as well as a specific group of patients struggling with long COVID.
Similar securities
Based on sector and market capitalization
Report issue